Status:
COMPLETED
Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial
Lead Sponsor:
Molly Tanenbaum
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This study is a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers \& Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with T1D the skills ...
Detailed Description
The investigators will enroll 178 adults with T1D between 18-50 years of age. Participants must not have been using CGM regularly for past 6 months. Once consented and enrolled, baseline demographic a...
Eligibility Criteria
Inclusion
- Subject is age 18-50 years at time of enrollment
- Subject must not have been using CGM regularly for past 6 months
- Subject has a clinical diagnosis of type 1 diabetes
- Subject comprehends spoken and written English
Exclusion
- Subject has a medical disorder that in the judgment of the investigator will interfere with completion of any aspect of the protocol.
- Subject has a neurologic disorder that in the judgment of the investigator will affect completion of the protocol.
Key Trial Info
Start Date :
February 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04672655
Start Date
February 17 2021
End Date
September 16 2024
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305